Plus Therapeutics (PSTV) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Plus Therapeutics Revenue Highlights

Latest Revenue (Q)

$1.06M

Main Segment (Y)

Grant

Main Geography (Y)

Product

Plus Therapeutics Revenue by Period

Plus Therapeutics Revenue by Year

Date	Revenue	Change
2024-12-31	-	-100.00%
2023-12-31	$4.91M	2093.30%
2022-12-31	$224.00K	100.00%
2021-12-31	-	-100.00%
2020-12-31	$303.00K	-95.67%
2019-12-31	$7.00M	134.60%
2018-12-31	$2.98M	-53.47%
2017-12-31	$6.41M	-43.66%
2016-12-31	$11.38M	-2.39%
2015-12-31	$11.66M	53.45%
2014-12-31	$7.60M	-37.70%
2013-12-31	$12.20M	-15.90%
2012-12-31	$14.50M	45.07%
2011-12-31	$10.00M	-5.94%
2010-12-31	$10.63M	19.50%
2009-12-31	$8.89M	96.40%
2008-12-31	$4.53M	-25.14%
2007-12-31	$6.05M	-23.69%
2006-12-31	$7.93M	40.70%
2005-12-31	$5.63M	-17.37%
2004-12-31	$6.82M	-51.60%
2003-12-31	$14.09M	53.70%
2002-12-31	$9.17M	62.29%
2001-12-31	$5.65M	-9.65%
2000-12-31	$6.25M	313.15%
1999-12-31	$1.51M	100.00%
1998-12-31	-	-

Plus Therapeutics generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Plus Therapeutics Revenue by Quarter

Date	Revenue	Change
2025-03-31	$1.06M	100.00%
2024-12-31	-	100.00%
2024-09-30	-	-100.00%
2024-06-30	$1.28M	-23.73%
2024-03-31	$1.68M	27.72%
2023-12-31	$1.31M	5.89%
2023-09-30	$1.24M	-33.12%
2023-06-30	$1.85M	100.00%
2023-03-31	-	-100.00%
2022-12-31	$224.00K	100.00%
2022-09-30	-	100.00%
2022-06-30	-	100.00%
2022-03-31	-	100.00%
2021-12-31	-	100.00%
2021-09-30	-	100.00%
2021-06-30	-	100.00%
2021-03-31	-	100.00%
2020-12-31	-	100.00%
2020-09-30	-	-100.00%
2020-06-30	$185.00K	56.78%
2020-03-31	$118.00K	-90.07%
2019-12-31	$1.19M	-75.10%
2019-09-30	$4.77M	1479.80%
2019-06-30	$302.00K	-79.03%
2019-03-31	$1.44M	-32.55%
2018-12-31	$2.13M	62.73%
2018-09-30	$1.31M	-15.84%
2018-06-30	$1.56M	-5.40%
2018-03-31	$1.65M	7.85%
2017-12-31	$1.53M	-13.82%
2017-09-30	$1.77M	18.20%
2017-06-30	$1.50M	-6.77%
2017-03-31	$1.61M	-46.85%
2016-12-31	$3.03M	15.98%
2016-09-30	$2.61M	-7.61%
2016-06-30	$2.83M	-3.19%
2016-03-31	$2.92M	-13.57%
2015-12-31	$3.38M	36.29%
2015-09-30	$2.48M	-28.43%
2015-06-30	$3.46M	47.53%
2015-03-31	$2.35M	-37.76%
2014-12-31	$3.77M	241.70%
2014-09-30	$1.10M	-14.56%
2014-06-30	$1.29M	-9.97%
2014-03-31	$1.43M	-58.55%
2013-12-31	$3.46M	27.63%
2013-09-30	$2.71M	19.59%
2013-06-30	$2.27M	-39.68%
2013-03-31	$3.76M	-48.70%
2012-12-31	$7.33M	456.69%
2012-09-30	$1.32M	-69.93%
2012-06-30	$4.38M	194.88%
2012-03-31	$1.48M	79.88%
2011-12-31	$825.00K	-61.43%
2011-09-30	$2.14M	-11.68%
2011-06-30	$2.42M	-6.74%
2011-03-31	$2.60M	-1.22%
2010-12-31	$2.63M	73.07%
2010-09-30	$1.52M	-27.60%
2010-06-30	$2.10M	-52.42%
2010-03-31	$4.41M	53.25%
2009-12-31	$2.88M	106.83%
2009-09-30	$1.39M	-83.71%
2009-06-30	$8.54M	344.84%
2009-03-31	$1.92M	-1216.28%
2008-12-31	$-172.00K	-107.41%
2008-09-30	$2.32M	65.24%
2008-06-30	$1.40M	817.65%
2008-03-31	$153.00K	537.50%
2007-12-31	$24.00K	-

Plus Therapeutics generated $1.06M in revenue during Q1 2025, up 100.00% compared to the previous quarter, and up 80.65% compared to the same period a year ago.

Plus Therapeutics Revenue Breakdown

Plus Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 22	Dec 19	Dec 18
Grant	$224.00K	-	-
Product	-	$901.00K	$2.67M
Consumable	-	-	$2.17M
Device	-	-	$225.00K
Other Products	-	-	$277.00K

Plus Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 22: Grant (100.00%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Sep 23	Mar 23	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
Grant	$1.46M	$1.28M	$1.24M	$506.00K	-	-	-	-	-
Consumable	-	-	-	-	$663.00K	$324.00K	$692.00K	$594.00K	$559.00K
Other Products	-	-	-	-	$40.00K	$67.00K	$65.00K	$66.00K	$78.00K
Product	-	-	-	-	$703.00K	-	-	-	-
Device	-	-	-	-	-	$31.00K	$101.00K	$94.00K	$94.00K

Plus Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Grant (100.00%).

Plus Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 19	Dec 18
Product	$901.00K	-
Asia Pacific	-	$50.00K
E M E A	-	$270.00K
JAPAN	-	$2.06M
Americas	-	$293.00K

Plus Therapeutics's latest annual revenue breakdown by geography, as of Dec 19: Product (100.00%).

Quarterly Revenue by Country

Country	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
E M E A	$150.00K	$8.00K	$114.00K	$57.00K	$90.00K
Consumable	$663.00K	-	-	-	-
Other Products	$40.00K	-	-	-	-
Product	$703.00K	-	-	-	-
JAPAN	$419.00K	$365.00K	$535.00K	$581.00K	$578.00K
Asia Pacific	$70.00K	$5.00K	$10.00K	$16.00K	$18.00K
Americas	$64.00K	$44.00K	$199.00K	$6.00K	$45.00K

Plus Therapeutics's latest quarterly revenue breakdown by geography, as of Mar 19: Product (33.33%), Consumable (31.44%), JAPAN (19.87%), E M E A (7.11%), Asia Pacific (3.32%), Americas (3.03%), and Other Products (1.90%).

Plus Therapeutics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ADAP	Adaptimmune Therapeutics	$178.03M	$7.29M
FGEN	FibroGen	$29.62M	$1.35M
GBIO	Generation Bio	$19.89M	$765.00K
VRCA	Verrica Pharmaceuticals	$7.57M	$12.70M
EYEN	Eyenovia	$57.34K	$14.72K
OKUR	OnKure Therapeutics	-	-
RVPH	Reviva Pharmaceuticals	-	-
PDSB	PDS Bio	-	-
IOBT	IO Biotech	-	-
JSPR	Jasper Therapeutics	-	-
PSTV	Plus Therapeutics	-	$1.06M

PSTV Revenue FAQ

What is Plus Therapeutics’s yearly revenue?

Plus Therapeutics's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $4.91M, representing an increase of 2093.30% compared to 2022. PSTV's yearly revenue for 2022 was $224K, representing an increase of 100.00% compared to 2021.

What is Plus Therapeutics’s quarterly revenue?

Plus Therapeutics's quarterly revenue for Q1 2025 was $1.06M, a 100.00% increase from the previous quarter (Q4 2024), and a -36.85% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $0, a 100.00% increase from the previous quarter (Q3 2024), and a -100.00% decrease year-over-year (Q4 2023). PSTV's quarterly revenue for Q3 2024 was $0, a -100.00% decrease from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023).

What is Plus Therapeutics’s revenue growth rate?

Plus Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are Plus Therapeutics’s revenue streams?

Plus Therapeutics's revenue streams in c 22 are Grant

What is Plus Therapeutics’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of Plus Therapeutics was Grant. This segment made a revenue of $224K, representing 100.00% of the company's total revenue.